…actions based on analyses and pilot projects, focusing on innovation, research mobility and business use of research facilities A common strategy for developing ÖKS-Hamburg into a globally competitive research region….
…EST@maxiv.lu.se if you have queries or require support. Complete Safety Test The safety training is mandatory for gaining access to the MAX IV building. Download the reading materials for your…
Some grand common challenges in certain fields of science have motivated the user community and funding bodies from neighboring countries to develop projects aiming at the design and construction of…
…Cullinan, and Å. Andersson https://doi.org/10.1103/PhysRevAccelBeams.21.120701 Commissioning and first-year operational results of the MAX IV 3 GeV ring J. Synchrotron Rad. (2018). 25, 1291-1316 P. F. Tavares, E. Al-Dmour, Å. Andersson,…
…using X-ray methods. Principles of pharmaceutical interactions in the gastrointestinal tract. Illustration: KU “Being a physical chemist, it is particularly exciting to explore different analytical avenues that may each hold…
…Radiation Facility (ESRF) in Grenoble, France. Simon Herzog onsite for sampling at the Mörrum River. Credit: Emma Kritzberg Results revealed the presence of organic iron complexes (Fe-OM) in higher abundance…
…conversion using bacterial enzyme, glucuronoyl esterase (GE) OtCE15A on a highly complex substrate, lignin carbohydrate complex (LCC). With measurements at BioMAX beamline, the step of deacylation, which removes an acyl…
Prepare for a successful PRISMAS application by writing a compelling cover letter and gathering the required documents. Here is everything you need to know to start your PRISMAS journey. When applying for…
…the cutting tools when being used, but detecting the initial stage of decomposition in the local chemical environment requires other methods. Studying changes in the atomic structures using Balder beamline…
…point. However, current commercial Keap1-targeting drugs covalently inhibit Keap1, a mechanism of action that comes with a lack of selectivity, side effects, and other complications during drug development. “Through this…